Glioblastoma Clinical Trials in Boston, MA

Glioblastoma Clinical Trials in Boston, MA

View the best 10 glioblastoma medical studies in Boston, Massachusetts. Access promising new therapies by applying to a Boston-based Glioblastoma clinical trial.

Trials in Boston, Massachusetts

Here are the top 10 medical studies for glioblastoma in Boston, Massachusetts

Image of Investigation Site in Newark, United States.

IGV-001 +2 More

Cell Immunotherapy

Recruiting0 awardsPhase 2
This trial will compare a new treatment for glioblastoma to placebo to see if it extends survival.
Image of Princess Margaret Cancer Center in Toronto, Canada.

RO7428731

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial tests a new drug, RO7428731, for safety and effectiveness in patients with a specific type of brain cancer (glioblastoma) that has a particular mutation. The drug works by targeting and binding to the mutated cancer cells to stop their growth. This mutation is common in glioblastoma and makes the cancer grow faster and resist standard treatments.
Image of Children's Hospital of Alabama in Birmingham, United States.

Selpercatinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial will test how well selpercatinib works in treating patients with advanced solid tumors, lymphomas, or histiocytic disorders that have activating RET gene alterations.
Image of Massachusetts General Hospital in Boston, United States.

Personalized NeoAntigen Vaccine +1 More

Cancer Vaccine

Recruiting1 awardPhase 1
This trial is studying a new type of vaccine as a possible treatment for patients with glioblastoma. It is evaluating the safety of the vaccine and finding the right dose to use.
Image of Brigham and Women Hospital in Boston, United States.

MRI IMAGING

Recruiting1 award10 criteria
This trial is to study if using MRIs to track response to radiation therapy is feasible and useful for patients with certain types of cancer.
Image of Children's Hospital Los Angeles in Los Angeles, United States.

BGB-290 +1 More

PARP Inhibitor

Recruiting1 awardPhase 1
This trial studies the safety and best dose of BGB-290 and temozolomide in treating young people with a specific type of brain tumor. BGB-290 blocks enzymes needed for tumor growth, while temozolomide kills or stops cancer cells from growing. The goal is to find out if this combination works better for these patients.
Image of Children's Hospital of Los Angeles in Los Angeles, United States.

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 1
This trial studies the effects of nivolumab, an immunotherapy drug, in children and young adults with severe brain cancer that has returned or worsened. The drug helps the immune system fight the cancer and may prevent it from growing.
Image of Illinois CancerCare-Bloomington in Bloomington, United States.

Atezolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial tests a combination of tocilizumab, atezolizumab, and precise radiation therapy in patients with recurrent glioblastoma. Tocilizumab reduces inflammation, atezolizumab boosts the immune system, and the radiation targets the tumor. The goal is to make the tumor more responsive to treatment and improve patient outcomes.
Image of University of Alabama at Birmingham in Birmingham, United States.

OKN-007 +1 More

Chemotherapy

Recruiting1 awardPhase 2
This trial is testing a new drug called OKN-007 combined with a chemotherapy drug, temozolomide, in patients whose brain cancer has returned after standard treatments. OKN-007 may help reduce tumor growth and make the chemotherapy more effective. Temozolomide is effective in treating malignant brain tumors.
Image of Children's Hospital of Alabama in Birmingham, United States.

Tazemetostat

EZH2 Inhibitor

Recruiting1 awardPhase 2
This trial studies how well tazemetostat works in children with certain difficult-to-treat cancers that have specific gene mutations. Tazemetostat is a pill that aims to stop cancer cell growth by blocking a specific protein. The goal is to see if this treatment can help these children when other treatments have failed. Tazemetostat is already approved for treating various cancers, including certain brain tumors in children.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.